Skip to main content

Benzinga's Top Analyst Calls From April 10, 2018

By: via Benzinga
Maxim raises BeiGene Ltd (NASDAQ: BGNE) price target from $160 to $200; Says the company continues to advance its clinical ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.